Synthesis, characterization, and efficacy of antimicrobial chlorhexidine hexametaphosphate nanoparticles for applications in biomedical materials and consumer products

International Journal of Nanomedicine

Volumn 8, Issue , 2013, Pages 3507-3519

  Barbour, Michele E ^a   Maddocks, Sarah E ^b   Wood, Natalie J ^a   Collins, Andrew M ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b CARDIFF METROPOLITAN UNIVERSITY   (United Kingdom)

Author keywords

Biomaterials; Chlorhexidine; Drug delivery; Mrsa; Slow release

Indexed keywords

ANTIINFECTIVE AGENT; BIOMEDICAL AND DENTAL MATERIALS; CHLORHEXIDINE GLUCONATE; CHLORHEXIDINE HEXAMETAPHOSPHATE NANOPARTICLE; ELASTOMER; GLASS; HEXAMETAPHOSPHATE SODIUM; NANOPARTICLE; TITANIUM; UNCLASSIFIED DRUG;

ADHESION; AQUEOUS SOLUTION; ARTICLE; BIOFILM; CHEMICAL REACTION; COLLOID; DRUG EFFICACY; DRUG SYNTHESIS; LEACHING; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NONHUMAN; PLANKTON; PRESSURE; PSEUDOMONAS AERUGINOSA; ROOM TEMPERATURE; SURFACE CHARGE; WOUND DRESSING;

BIOMATERIALS; CHLORHEXIDINE; DRUG DELIVERY; MRSA; SLOW RELEASE;

ADSORPTION; ANTI-INFECTIVE AGENTS; BACTERIAL PHYSIOLOGICAL PHENOMENA; CELL SURVIVAL; CHLORHEXIDINE; COATED MATERIALS, BIOCOMPATIBLE; DRUG COMPOUNDING; NANOPARTICLES; PHOSPHATES;

EID: 84884548389     PISSN: 11769114     EISSN: 11782013     Source Type: Journal    
DOI: 10.2147/IJN.S50140     Document Type: Article

References (24)

1. McDonnell G, Russell AD. Antiseptics and disinfectants: activity, action, and resistance. Clin Microbiol Rev. 1999;12(1):147-179.
2. Meyer B, Cookson B. Does microbial resistance or adaptation to biocides create a hazard in infection prevention and control? J Hosp Infect. 2010;76(3):200-205.
3. Milstone AM, Passaretti CL, Perl TM. Chlorhexidine: expanding the armamentarium for infection control and prevention. Clin Infect Dis. 2008;46(2):274-281.
4. Barbour ME, Gandhi N, el-Turki A, O'Sullivan DJ, Jagger DC. Differential adhesion of Streptococcus gordonii to anatase and rutile titanium dioxide surfaces with and without functionalization with chlorhexidine. J Biomed Mater Res A. 2009;90(4):993-998.
5. Raad I, Mohamed JA, Reitzel RA, et al. Improved antibiotic-impregnated catheters with extended-spectrum activity against resistant bacteria and fungi. Antimicrob Agents Chemother. 2012;56(2):935-941.
6. Verraedt E, Pendela M, Adams E, Hoogmartens J, Martens JA. Controlled release of chlorhexidine from amorphous microporous silica. J Control Release. 2010;142(1):47-52.
7. Cheng L, Weir MD, Xu HH, et al. Antibacterial and physical properties of calcium-phosphate and calcium-fluoride nanocomposites with chlorhexidine. Dent Mater. 2012;28(5):573-583.
8. Fong N, Poole-Warren LA, Simmons A. Development of sustained-release antibacterial urinary biomaterials through using an antimicrobial as an organic modifier in polyurethane nanocomposites. J Biomed Mater Res Part B Appl Biomater. 2013;101(2):310-319.
9. Barbour ME, O'Sullivan DJ, Jagger DC. Chlorhexidine adsorption to anatase and rutile titanium dioxide. Colloid Surface A: Physiochemical and Engineering Aspects. 2007;307(1-3):116-120.
10. BSAC. BSAC Methods for Antimicrobial Susceptibility Testing. Ver-sion 11.1. Birmingham: British Society for Antimicrobial Chemotherapy; 2012. Available from: http://bsac.org.uk/wp-content/uploads/2012/02/Version-11.1-2012-Final-.pdf. Accessed August 8, 2013.
11. Miles AA, Misra SS, Irwin JO. The estimation of the bactericidal power of the blood. J Hyg (Lond). 1938;38(6):732-749.
12. Hanaor D, Michelazzi M, Leonelli C, Sorrell CC. The effects of carboxylic acids on the aqueous dispersion and electrophoretic deposition of ZrO2. J Eur Ceram Soc. 2012;32(1):235-244.
13. Gottrup F, Apelqvist J, Price P; European Wound Management Association Patient Outcome Group. Outcomes in controlled and comparative studies on non-healing wounds: recommendations to improve the quality of evidence in wound management. J Wound Care. 2010;19(6):237-268.
14. James GA, Swogger E, Wolcott R, et al. Biofilms in chronic wounds. Wound Repair Regen. 2008;16(1):37-44.
15. Ammons MC. Anti-biofilm strategies and the need for innovations in wound care. Recent Pat Antiinfect Drug Discov. 2010;5(1):10-17.
16. Storm-Versloot MN, Vos CG, Ubbink DT, Vermeulen H. Topical silver for preventing wound infection. Cochrane Database Syst Rev. 2010CD006478.
17. Sofokleous P, Stride E, Edirisinghe M. Preparation, characterization, and release of amoxicillin from electrospun fibrous wound dressing patches. Pharm Res. 2013;30(7):1926-1938.
18. Eardley WG, Watts SA, Clasper JC. Limb wounding and antisepsis: iodine and chlorhexidine in the early management of extremity injury. Int J Low Extrem Wounds. 2012;11(3):213-223.
19. Wu SC, Crews RT, Zelen C, Wrobel JS, Armstrong DG. Use of chlorhexidine-impregnated patch at pin site to reduce local morbidity: the ChIPPS Pilot Trial. Int Wound J. 2008;5(3):416-422.
20. Agarwal A, Nelson TB, Kierski PR, et al. Polymeric multilayers that localize the release of chlorhexidine from biologic wound dressings. Biomaterials. 2012;33(28):6783-6792.
21. Türkün LS, Türkün M, Ertuǧrul F, Ateş M, Brugger S. Long-term anti-bacterial effects and physical properties of a chlorhexidine-containing glass ionomer cement. J Esthet Restor Dent. 2008;20(1):29-44.
22. Hu G, Xiao L, Tong P, et al. Antibacterial hemostatic dressings with nanoporous bioglass containing silver. Int J Nanomedicine. 2012;7: 2613-2620.
23. Renoud P, Toury B, Benayoun S, Attik G, Grosgogeat B. Functionalization of titanium with chitosan via silanation: evaluation of biological and mechanical performances. PLoS ONE. 2012;7(7):e39367.
24. Hickok NJ, Shapiro IM. Immobilized antibiotics to prevent orthopaedic implant infections. Adv Drug Deliv Rev. 2012;64(12):1165-1176.